Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Bioavailability of HRS-1893 in Healthy Subjects
NCT07272330Phase 1Completed
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Dec 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of HRS-1893 in cardiomyopathy (2 arms), sponsored by Shandong Suncadia Medicine Co., Ltd. Primary endpoints: Peak concentration, Area under the plasma concentration-time curve from time zero to the last quantifiable time point and 1 more. Started Dec 2025; status: completed.
02
Drugs
HRS-1893
03
Conditions
cardiomyopathy
Beyond the preview
Go deeper on NCT07272330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07272330.